BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20200964)

  • 1. Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS.
    Salovaara K; Tuppurainen M; Kärkkäinen M; Rikkonen T; Sandini L; Sirola J; Honkanen R; Alhava E; Kröger H
    J Bone Miner Res; 2010 Jul; 25(7):1487-95. PubMed ID: 20200964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium plus vitamin D supplementation and the risk of fractures.
    Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
    N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis.
    Bergman GJ; Fan T; McFetridge JT; Sen SS
    Curr Med Res Opin; 2010 May; 26(5):1193-201. PubMed ID: 20302551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
    Pentti K; Tuppurainen MT; Honkanen R; Sandini L; Kröger H; Alhava E; Saarikoski S
    Maturitas; 2009 May; 63(1):73-8. PubMed ID: 19394167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
    Dawson-Hughes B; Harris SS; Krall EA; Dallal GE
    N Engl J Med; 1997 Sep; 337(10):670-6. PubMed ID: 9278463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.
    Boonen S; McClung MR; Eastell R; El-Hajj Fuleihan G; Barton IP; Delmas P
    J Am Geriatr Soc; 2004 Nov; 52(11):1832-9. PubMed ID: 15507059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group.
    Ensrud KE; Stone K; Cauley JA; White C; Zmuda JM; Nguyen TV; Eisman JA; Cummings SR
    J Bone Miner Res; 1999 Oct; 14(10):1637-45. PubMed ID: 10491209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
    Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
    Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
    Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
    Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study.
    Larsen ER; Mosekilde L; Foldspang A
    J Bone Miner Res; 2004 Mar; 19(3):370-8. PubMed ID: 15040824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does hormone-replacement therapy prevent fractures in early postmenopausal women?
    Randell KM; Honkanen RJ; Kröger H; Saarikoski S
    J Bone Miner Res; 2002 Mar; 17(3):528-33. PubMed ID: 11874244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial.
    Meyer HE; Smedshaug GB; Kvaavik E; Falch JA; Tverdal A; Pedersen JI
    J Bone Miner Res; 2002 Apr; 17(4):709-15. PubMed ID: 11918228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
    J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.